DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Sai Life Sciences Limited — Outcome of Board Meeting

NSE 2 hrs ago·6 Aug 2026, 5:10 pm

SAI Life Sciences

Sai Life Sciences has announced its unaudited financial results for the quarter ended June 30, 2026. The company submitted these standalone and consolidated figures to the stock exchange, marking the standard reporting period for interim performance.

For investors, this update provides a crucial snapshot of the company's operational health and financial trajectory. It helps gauge the company's ability to manage costs and generate revenue during the ongoing fiscal period, offering insights into its current market position.

Investors should monitor the company's commentary on its key performance indicators, including revenue growth and operating margins. Keeping an eye on future guidance will be essential to understand the management's outlook for the remainder of the fiscal year.